Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)

Completed · Not applicable

Conditions studied: HIV, Depression, HIV Infections

In brief

This study will test a therapy for both helping people adhere to their HIV medication regimens and treating them for depression.

Key facts

Study ID

NCT00951028

Run by

Massachusetts General Hospital

People needed

240

Starts

2008-09-01

Expected to finish

2013-04-01

Last updated by the study team

2013-06-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV-infected
• Current diagnosis of depression or prescribed an antidepressant medication with at least some residual symptoms (e.g., clinical global impressions [CGI] scale score of 2 or greater)
• Prescribed a stable regimen of highly active antiretroviral therapy (HAART) for HIV for at least 2 months

You may not qualify if…

• Active, untreated, and unstable major mental illness (i.e., untreated psychosis or mania) that would interfere with cognitive behavioral therapy (CBT) treatment for depression
• Diagnosis with any primary psychotic disorder, even if treated
• Treatment with CBT within the past year

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States
• Fenway Community Health Center — Boston, Massachusetts, United States
• Butler Hospital — Providence, Rhode Island, United States
• The Miriam Hospital — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.